Investor Alert

press release

Oct. 11, 2021, 8:01 a.m. EDT

Horizon Therapeutics plc to Release Third-Quarter 2021 Financial Results and Host Webcast on Nov. 3, 2021

DUBLIN, (BUSINESS WIRE) -- Horizon Therapeutics plc /zigman2/quotes/206690250/composite HZNP -0.29% announced today that its third-quarter 2021 financial results will be released on Wednesday, Nov. 3, 2021. Following the announcement, Horizon's management will host a live webcast at 8 a.m. Eastern Time to review the Company's financial and operating results.

The live webcast and a replay may be accessed at http://ir.horizontherapeutics.com . Please connect to the Company's website at least 15 minutes prior to the live webcast to ensure adequate time for any software download that may be needed to access the webcast. A replay of the webcast will be available approximately two hours after the live webcast.

About Horizon

Horizon is focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. Our pipeline is purposeful: we apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, please visit www.horizontherapeutics.com and follow us on Twitter , LinkedIn , Instagram and Facebook .

View source version on businesswire.com: https://www.businesswire.com/news/home/20211011005162/en/

SOURCE: Horizon Therapeutics plc

Tina Ventura
Senior Vice President,
Investor Relations

Ruth Venning
Executive Director,
Investor Relations

U.S. Media:
Geoff Curtis
Executive Vice President,
Corporate Affairs & Chief Communications Officer

Ireland Media:
Ray Gordon
Gordon MRM


Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

Copyright Business Wire 2021

US : U.S.: Nasdaq
$ 86.60
-0.25 -0.29%
Volume: 1.52M
Jan. 25, 2022 4:00p
P/E Ratio
Dividend Yield
Market Cap
$19.70 billion
Rev. per Employee


Partner Center

Link to MarketWatch's Slice.